杭州大型工业吸尘器泰州工业吸尘器厂家,枣庄工业吸尘器厂家,黄石工业吸尘器,营口工业吸尘器厂家,曲靖大功率工业吸尘器,大庆大型工业吸尘器,儋州工业吸尘器

SAN DIEGO (CNS) - A 69-year-old man was hospitalized this morning with a broken leg he sustained in a hit-and-run crash in the Teralta West neighborhood.The pedestrian was crossing northbound at the intersection of Orange and Central avenues at 10:15 p.m. Friday when a vehicle driving east on Orange Avenue turned north onto Central Avenue and struck the man, according to Officer Robert Heims of the San Diego Police Department.The vehicle backed up after the crash, then drove away west on Orange Avenue, Heims said.The victim sustained non-life-threatening injuries and was taken to a hospital, Heims said.The suspect vehicle was described as a light-colored, 4-door sedan, possibly a Pontiac G6 or similar vehicle. A description of the driver was not available. 774

SAN DIEGO (CNS) - A hit-and-run driver struck a motorcyclist early Wednesday morning in the Fairmont Village neighborhood, leaving the rider with a broken leg, police said.The crash was reported around 12:10 a.m. at the intersection of Lantana Drive and Euclid Avenue, San Diego police Officer John Buttle said.A 33-year-old man was riding a Yamaha motorcycle northbound on Euclid Avenue when a vehicle pulled out from Lantana Drive and struck the right side of the motorcycle, Buttle said.The rider was taken to a hospital for treatment of a fractured tibia and fibula, the officer said.The suspect vehicle, described as a white Honda sedan, was last seen heading southbound on Euclid Avenue, Buttle said.A description of the hit-and-run driver was not immediately available. 784

SAN DIEGO (AP) — A California tribe whose ancestral lands span across the U.S.-Mexico border is suing the Trump administration to block construction of a section of border wall that the Kumeyaay people say is desecrating sacred burial sites. The La Posta Band of Diegueno Mission Indians filed the lawsuit in federal court in San Diego on Tuesday seeking to temporarily halt construction of the wall until the tribe can protect its religious and cultural heritage. La Posta is one of 12 bands of the Kumeyaay people. The tribe wants its members to be able to monitor work and interrupt it to recover human remains and cultural items uncovered during construction. Federal officials did not immediately respond to a request for comment. 743

SACRAMENTO, Calif. (KGTV) — California State University's Board of Trustees voted Wednesday to make ethnic studies a graduation requirement.The vote will modify the university's general education requirements to include a course addressing ethnic studies and social justice, according to the college system. The one-course requirement will be implemented in the 2023-24 school year to allow time for faculty to develop plans and coursework."Our goal is for CSU students, from every major and in every workplace, to be leaders in creating a more just and equitable society," said CSU Chancellor Timothy White. "This action, by the CSU and for the CSU, lifts Ethnic Studies to a place of prominence in our curriculum, connects it with the voices and perspectives of other historically oppressed groups, and advances the field by applying the lens of social justice. It will empower our students to meet this moment in our nation’s history, giving them the knowledge, broad perspectives and skills needed to solve society’s most pressing problems. And it will further strengthen the value of a CSU degree."RELATED: Report: Enrollment demand does not warrant Chula Vista CSU campusThe change is the first significant modification to the system's GE requirements in 40 years, amid a nationwide focus at police reform and racial justice.CSU says the requirement can be fulfilled through course offerings that "address historical, current and emerging ethnic studies and social justice issues.""CSU courses on Africana literature, Native Californian perspectives, police reform, disparities in public health and the economics of racism, to name just a few, would meet the new requirement," the university adds, in addition to its traditional ethnic studies curriculum. 1769

SAN DIEGO (CNS) - A COVID-19 vaccine trial sponsored by drugmaker Johnson & Johnson is slated to get underway soon in San Diego, and will include an estimated 2,000 participants at UC San Diego Health, it was announced Thursday.Up to 60,000 participants will be recruited from 10 different countries around the world as the San Diego portion of the trial, dubbed ENSEMBLE, gets underway Oct. 7, according to UCSD.The efficacy, safety and immunogenicity of the drug Ad.26-COV2.S will be tested via a randomized, double-blind, placebo-controlled study, in which half of the participants receive a single-dose injection of the vaccine and the other half receive a placebo. All participants -- who must be 18 years of age or older and in reasonably good health -- will be monitored for signs of infection and COVID-19 over the next two years, according to UCSD.Researchers are particularly interested in recruiting participants at increased risk of SARS-CoV-2 infection due to where they live, their age or personal circumstances, such as working in essential jobs like first responders, health care, maintenance, construction, grocery stores or assisted living facilities.The San Diego trial will also emphasize participation from the region's underserved communities, as communities of color have shown higher rates of COVID-19-related hospitalization and/or death.UCSD cited data from the county showing measurably higher infection rates in the South Bay, including in Chula Vista, Imperial Beach and National City.Susan Little, professor of medicine at UC San Diego School of Medicine and principal investigator of the UC San Diego trial, said, "Many communities of color are experiencing higher rates of hospitalization related to COVID-19 than are observed in white, non-Hispanic people. It is important that these communities are represented in COVID-19 vaccine clinical trials so that we understand if the vaccine will work well within these groups."For more information about participating in the trial at UC San Diego, go to www.covidvaccinesd.com or call 619-742-0433. 2087